Vitamin D‐binding protein and 25‐hydroxyvitamin D during pregnancy in mothers whose children later developed type 1 diabetes

Levels of 25‐hydroxyvitamin D (25‐OH D) during late pregnancy have been linked to type 1 diabetes risk in the offspring. Vitamin D‐binding protein increases in concentration during pregnancy. We aimed to test whether concentrations of vitamin D‐binding protein and 25‐OH D throughout pregnancy differed between women whose offspring later developed type 1 diabetes (cases) and controls.

[1]  E. Gale,et al.  The prenatal environment and type 1 diabetes , 2013, Diabetologia.

[2]  J. Vaupel,et al.  Pre-analytical stability of the plasma proteomes based on the storage temperature , 2013, Proteome Science.

[3]  C. Mathieu,et al.  Effects of vitamin D on antigen‐specific and non‐antigen‐specific immune modulation: relevance for type 1 diabetes , 2013, Pediatric diabetes.

[4]  A. Ascherio,et al.  Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel. , 2013, American journal of epidemiology.

[5]  R. Chun.  New perspectives on the vitamin D binding protein , 2012, Cell biochemistry and function.

[6]  Alex J. Brown,et al.  Bioavailable vitamin D in chronic kidney disease. , 2012, Kidney international.

[7]  M. Blankenstein,et al.  Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. , 2012, Clinical chemistry.

[8]  J. Adams,et al.  Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling , 2012, PloS one.

[9]  L. Kinnunen,et al.  Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring , 2012, Diabetologia.

[10]  P. Jenum,et al.  Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring , 2011, Diabetes.

[11]  M. Rewers,et al.  No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY) , 2011, Diabetologia.

[12]  J. She,et al.  Reduced Serum Vitamin D–Binding Protein Levels Are Associated With Type 1 Diabetes , 2011, Diabetes.

[13]  I. Bhan,et al.  Vitamin D–Binding Protein Modifies the Vitamin D–Bone Mineral Density Relationship , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  C. Hawrylowicz,et al.  A direct role for vitamin D-binding protein in the pathogenesis of COPD? , 2011, Thorax.

[15]  R. Stockley,et al.  Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages , 2011, Thorax.

[16]  B. Han,et al.  Proteomic analysis of the effect of storage temperature on human serum. , 2010, Annals of clinical and laboratory science.

[17]  M. Lehtinen,et al.  The Effects of Storage Time and Sampling Season on the Stability of Serum 25-Hydroxy Vitamin D and Androstenedione , 2009, Nutrition and cancer.

[18]  H. DeLuca.  Evolution of our understanding of vitamin D. , 2008, Nutrition reviews.

[19]  J. Norris,et al.  Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. , 2008, The Journal of clinical endocrinology and metabolism.

[20]  M. Klebanoff,et al.  Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years , 2008, British Journal of Nutrition.

[21]  C. Carlberg,et al.  The vitamin D receptor. , 2007, Dermatologic clinics.

[22]  P. Magnus,et al.  Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. , 2007, Journal of autoimmunity.

[23]  Carly M. Kemmis,et al.  Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. , 2006, The Journal of nutrition.

[24]  P. Vestergaard,et al.  Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women , 2005, Calcified Tissue International.

[25]  M. Pinget,et al.  Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes. , 2005, Clinical biochemistry.

[26]  M. Holick.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[27]  M. Hewison,et al.  Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  M. Christiansen,et al.  Gc globulin (vitamin D‐binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum , 2004, Scandinavian Journal of Clinical and Laboratory Investigation.

[29]  GEORGE S. Eisenbarth.  Insulin Autoimmunity , 2003, Annals of the New York Academy of Sciences.

[30]  P. White,et al.  The Multifunctional Properties and Characteristics of Vitamin D-binding Protein , 2000, Trends in Endocrinology & Metabolism.

[31]  T. Klupa,et al.  Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. , 1999, European journal of endocrinology.

[32]  B. Stray-Pedersen,et al.  Incidence of Toxoplasma gondii Infection in 35,940 Pregnant Women in Norway and Pregnancy Outcome for Infected Women , 1998, Journal of Clinical Microbiology.

[33]  N. Yamamoto,et al.  Structurally well‐defined macrophage activating factor derived from vitamin D3‐binding protein has a potent adjuvant activity for immunization , 1998, Immunology and cell biology.

[34]  J. Haddad,et al.  Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. , 1986, The Journal of clinical endocrinology and metabolism.

[35]  T. Markestad,et al.  Plasma concentrations of vitamin D metabolites during puberty of diabetic children , 1985, Diabetologia.

[36]  J. Haddad,et al.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. , 1984, The Journal of clinical investigation.

[37]  R. Bouillon,et al.  Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. , 1981, The Journal of clinical investigation.

[38]  N. Napoli,et al.  Vitamin D and Diabetes Mellitus. , 2018, Frontiers of hormone research.

[39]  T. Skrivarhaug,et al.  Incidence of type 1 diabetes in Norway among children aged 0–14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry , 2013, Diabetologia.

[40]  M. Bissell.  Accuracy of 6 Routine 25-Hydroxyvitamin D Assays: Influence of Vitamin D Binding Protein Concentration , 2013 .

[41]  R. Bouillon.  The Vitamin D Binding Protein DBP , 2011 .

[42]  D. Bikle.  Nonclassic actions of vitamin D. , 2009, The Journal of clinical endocrinology and metabolism.

[43]  Christopher B Wilson,et al.  Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection , 2006 .

[44]  D. Black,et al.  Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles. , 2005, Clinical chemistry.

[45]  M. Hewison,et al.  Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. , 2004, The Journal of steroid biochemistry and molecular biology.

[46]  J. Aloia,et al.  Body fat content and 25-hydroxyvitamin D levels in healthy women. , 2003, The Journal of clinical endocrinology and metabolism.

[47]  C. Beaufort.  The EURODIAB Substudy 2 Study Group Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus , 1999 .